( NASDAQ-NMS:SIAL )

News from Sigma-Aldrich A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 10, 2015, 11:52 ET Sigma-Aldrich and Merck KGaA, Darmstadt, Germany, Obtain EC Antitrust Approval and Work Toward Closing Planned Acquisition

Sigma-Aldrich Corporation (NASDAQ:  SIAL) today announced it has secured final approval from the European Commission (EC) on the planned...


Nov 03, 2015, 07:00 ET Sigma-Aldrich (NASDAQ - SIAL) Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00

HIGHLIGHTS:  Q3 2015 Results (all percentage changes are against the comparable period in 2014) - Reported sales were $703 million...


Oct 29, 2015, 07:00 ET Sigma-Aldrich Acquires Duolink Product Portfolio from Olink Bioscience

 Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company, today announced that it has signed an agreement to...


Oct 20, 2015, 06:00 ET Sigma-Aldrich Announces Agreement on Assets Sale to Honeywell to Fulfill EU Commitments

 Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that it agreed to sell its Sigma-Aldrich-branded solvents and inorganics business in...


Oct 19, 2015, 10:48 ET Sigma-Aldrich Partners with Sanger Institute on First Arrayed Whole Genome Lentiviral CRISPR Libraries

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has entered into an agreement with the Wellcome Trust Sanger Institute to...


Aug 24, 2015, 18:00 ET Sigma-Aldrich Corporation Declares Quarterly Dividend

 Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company (the "Company"), announces a quarterly cash dividend...


May 06, 2015, 07:00 ET Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology

 Sigma-Aldrich Corporation (NASDAQ: SIAL) a leading life science and high technology company, today announced a $50,000 product donation...


Apr 21, 2015, 07:00 ET BioReliance Licenses B-CLEAR® Technology from Qualyst Transporter Solutions for Drug Transporter Studies

ST. LOUIS, April 21, 2015 /PRNewswire/ –BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation's (NASDAQ: SIAL) biologics...


Mar 20, 2015, 15:00 ET Sigma-Aldrich® Global Green Chemistry Initiative: Next Phase Kicked-off with Special Issue of Aldrichimica Acta

 Sigma-Aldrich Corporation (Nasdaq: SIAL), a leading life science and high technology company, today launched the next phase of its global...


Feb 18, 2015, 07:00 ET Sigma® Life Science Releases Next-Gen Sequencing Oligos

 Sigma-Aldrich Corporation (Nasdaq: SIAL) today announced that Sigma Life Science, its innovative biological products and services...


Oct 23, 2014, 07:02 ET Sigma-Aldrich (NASDAQ - SIAL) Reports Q3 2014 Results With Sales Of $690 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Per Share Quarterly Dividend.

HIGHLIGHTS: Q3 2014 Results (all percentage changes are against the same period in 2013) - Reported sales increased 4% to $690...


Oct 16, 2014, 07:00 ET BioReliance® Introduces Advanced In Vitro ADME and Toxicology Services Designed to Improve Drug Safety and Efficacy

BioReliance® (www.bioreliance.com), Sigma-Aldrich Corporation's (NASDAQ: SIAL) biologics and early-development services business under...


Sep 18, 2014, 07:00 ET Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership

 Sigma-Aldrich Corporation (Nasdaq: SIAL) announced today it has entered into a new gene editing partnership with the University of Michigan...


Sep 10, 2014, 07:00 ET Cerilliant Snap-N-Spike® | Snap-N-Shoot® Certified Reference Materials Now Available through Sigma-Aldrich Canada

 Sigma-Aldrich Corporation (NASDAQ: SIAL) is pleased to announce that its Cerilliant® branded products are now available through...


Jul 24, 2014, 07:00 ET Sigma-Aldrich (NASDAQ - SIAL) Reports Record Q2 2014 Results With Sales Of $701 Million And Diluted EPS Of $1.11. Raises Lower-End Of Full-Year 2014 Adjusted Diluted EPS Guidance To A New Range Of $4.32 To $4.40.

HIGHLIGHTS: Q2 2014 Results (all percentage changes are against the same period in 2013) - Reported sales increased 3% to $701...


May 07, 2014, 07:00 ET SAFC's Pharmorphix® Technologies and BioTools Align to Provide End-to-End Chiral Technology Tools and Services

Sigma-Aldrich® Corporation's (NASDAQ: SIAL) custom manufacturing and services business unit, SAFC Commercial (www.sigma-aldrich.com/safc), has...


May 06, 2014, 17:00 ET Sigma-Aldrich Corporation Declares Quarterly Dividend

 Sigma-Aldrich Corporation (NASDAQ:  SIAL), a leading Life Science and Technology company (the "Company"), announces a quarterly cash...


Apr 30, 2014, 07:00 ET Sigma-Aldrich® Named to CR Magazine's 100 Best Corporate Citizens List

Sigma-Aldrich Corporation (Nasdaq: SIAL) was recently named by Corporate Responsibility (CR) Magazine to its list of the 100 Best Corporate...


Nov 05, 2013, 07:00 ET SAFC® Partners with CatScI Ltd. to Offer Comprehensive Catalysis Services

Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services...


Oct 14, 2013, 07:00 ET SAFC® Invests in Commercial-Scale ADC Conjugation Manufacturing and Services; Expands HPAPI Manufacturing and Storage Capacity

Sigma-Aldrich Corporation's (NASDAQ: SIAL) custom manufacturing services business unit, SAFC® Commercial (www.sigma-aldrich.com/safc), is...


Oct 10, 2013, 07:00 ET Sigma-Aldrich® Increases Focus on Sustainability - Unveils Latest Global Citizenship Report Highlighting Major Milestones and Earns Recognition from the CDP for Second Year

 Sigma-Aldrich Corporation (NASDAQ: SIAL) today unveiled its latest Global Citizenship Report highlighting the Company's progress in driving...


Oct 01, 2013, 18:30 ET Sigma-Aldrich Announces Q3 2013 Earnings Conference Call

 Sigma-Aldrich Corporation (NASDAQ:  SIAL) will hold its quarterly conference call to discuss third quarter 2013 financial results on...


Sep 04, 2013, 07:00 ET BioReliance Opens New U.S. Clearance Services Laboratories; Completes Global Facility Upgrade Plan

 Sigma-Aldrich® Corporation's (NASDAQ: SIAL) BioReliance® (www.bioreliance.com), the biologics and early-development services...